BDBM445015 US10668167, Compound 24

SMILES C[C@]12C=CC(=O)C=C1[C@@H](F)C[C@H]1[C@@H]3C[C@H]4O[C@@H](c5ccc(Cc6ccc(N)cc6)cc5)O[C@@]4(C(=O)CO)[C@@]3(C)C[C@H](O)[C@@]12F

InChI Key InChIKey=JQFDYENGUWMLDJ-UHFFFAOYSA-N

Data  4 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 4 hits for monomerid = 445015   

TargetProgesterone receptor(Human)
Abbvie

US Patent
LigandChemical structure of BindingDB Monomer ID 445015BDBM445015(US10668167, Compound 24)
Affinity DataIC50: 8.90nMAssay Description:Small molecules were tested for progersterone receptor (PR) binding using a modification of the LanthaScreen TR-FRET Progesterone Receptor Coactivato...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/15/2021
Entry Details
US Patent

TargetGlucocorticoid receptor(Human)
Abbvie

US Patent
LigandChemical structure of BindingDB Monomer ID 445015BDBM445015(US10668167, Compound 24)
Affinity DataIC50: 13.8nMAssay Description:Small molecules were tested for glucocorticoid receptor (GR) binding using the Polarscreen Glucocorticoid Receptor Assay Kit, Red (ThermoFisher A 158...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/15/2021
Entry Details
US Patent

TargetAndrogen receptor(Human)
Abbvie

US Patent
LigandChemical structure of BindingDB Monomer ID 445015BDBM445015(US10668167, Compound 24)
Affinity DataIC50: 3.00E+4nMAssay Description:Small molecules were tested for androgen receptor (AR) binding using a modification of the LanthaScreen TR-FRET Androgen Receptor Coactivator Assay (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/15/2021
Entry Details
US Patent

TargetEstrogen receptor(Human)
Abbvie

US Patent
LigandChemical structure of BindingDB Monomer ID 445015BDBM445015(US10668167, Compound 24)
Affinity DataIC50: 3.00E+4nMAssay Description:Small molecules were tested for estrogen receptor (ER) alpha binding using a modification of the LanthaScreen TR-FRET Estrogen Receptor Alpha Coactiv...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/15/2021
Entry Details
US Patent